Adalimumab in severe plaque psoriasis of childhood: A multi‐center, retrospective real‐life study up to 52 weeks observation

Author:

Di Lernia Vito1,Bianchi Luca2,Guerriero Cristina3,Stingeni Luca4,Gisondi Paolo5,Filoni Angela6,Guarneri Claudio7,Belloni Fortina Anna8,Lasagni Claudia9,Simonetti Oriana10,Neri Iria11,Zangrilli Arianna2,Moretta Gaia3,Hansel Katharina4,Casanova Dahiana M.1,Girolomoni Giampiero5,Cannavò Serafinella P.7,Bonamonte Domenico6

Affiliation:

1. Dermatology UnitArcispedale Santa Maria Nuova, Azienda USL‐IRCCS di Reggio Emilia Reggio Emilia Italy

2. Department of DermatologyUniversity of Rome 'Tor Vergata' Rome Italy

3. Institute of DermatologyCatholic University‐Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

4. Department of Medicine, Section of Clinical, Allergological and Venereological DermatologyUniversity of Perugia Perugia Italy

5. Section of Dermatology and Venereology, Department of MedicineUniversity of Verona Verona Italy

6. Section of Dermatology, Department of Biomedical Science and Human OncologyUniversity of Bari Bari Italy

7. Department of Clinical and Experimental Medicine, Section of DermatologyUniversity of Messina Messina Italy

8. Pediatric Dermatology Unit, Department of Medicine DIMEDUniversity of Padova Padua Italy

9. Dermatology UnitAzienda Ospedaliero‐Universitaria Policlinico di Modena Modena Italy

10. Department of Clinical and Molecular Sciences, Dermatological UnitPolytechnic Marche University Ancona Italy

11. Division of Dermatology, Department of Experimental, Diagnostic, and Specialty Medicine, Sant'Orsola‐Malpighi HospitalUniversity of Bologna Bologna Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Reference10 articles.

1. Treatment of severe psoriasis in children: recommendations of an Italian expert group

2. Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation

3. Pediatric psoriasis: Evolving perspectives

4. Efficacy and safety of adalimumab after failure of other anti‐TNFα agents for plaque‐type psoriasis: clinician behavior in real life clinical practice;Esposito M.;The Journal of Dermatological Treatment,2018

5. European Medicines Agency2019https://www.ema.europa.eu/documents/productinformation/humira-epar-product-information_en.pdf

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3